Targeting alpha synuclein to improve constipation
A phase II open label trial of a novel drug targeting
A phase II open label trial of a novel drug targeting
A prostrate drug (Terazosin) has been shown to exert neuroprotective effects in animal models.
AUDIO VERSION AVAILABLE.
Regular home-based aerobic exercise appears to reduce the progression of Parkinson’s.
AUDIO VERSION AVAILABLE.
The SURE-PD trial has indicated inosine was effective at increasing urate levels and slowing disease progression in women, but not men.
AUDIO VERSION AVAILABLE.
Focus ultrasound (FUS) is a promising new area to improve delivery of drugs and neurotrophic factors
Evidence from preclinical studies supports case for a clinical trial of cysteamine in PwP